跳至主要内容
临床试验/NCT00603187
NCT00603187已完成1 期

Oral Administration of the GnRH Antagonist Acyline in Normal Men Part II: Multiple-dose Pharmacokinetics (Acyline-7/MER 104-02)

University of Washington2 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2008年1月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
4
试验地点
2
主要终点
Testosterone Blood Serum Concentration

研究概览

简要总结

We propose oral dosing of gastrointestinal permeation enhancement technology [GIPET] enhanced oral acyline at 20 mg everyday for one week to determine the steady-state (multiple-dose) pharmacokinetics of oral acyline in four normal, healthy young men.

详细描述

The purpose of this study is to test how the body responds to a new oral form of acyline given for seven days and to also look at the safety of oral acyline.

Acyline temporarily blocks the production of the hormone testosterone in healthy men. It has been tested in over 100 men in an injection form. This study will be testing acyline in a pill form for seven days.

This study may help develop an oral form of testosterone-blocker which may be useful in the treatment of diseases such as prostate cancer, premature puberty and possibly in a male contraceptive.

This study will evaluate a single dose of oral acyline given once a day for seven days and subsequent effects on Testosterone, FSH and LH blood serum concentrations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy male
  • 18-50 years of age
  • Non-smoker
  • Not taking any medications other than the study drug for the duration of the study.
  • Must be willing to use an accepted method of contraception during the study.

排除标准

  • BMI > 35
  • Abnormal evaluation on screening exam and labs
  • Known history of alcohol abuse, illicit drugs or steroids and/or use of more that 3 alcoholic beverages/day
  • History of current testosterone use or infertility
  • History of testicular disease or severe testicular trauma
  • History of major psychiatric disorder or sleep apnea
  • History of bleeding disorder or need for anticoagulation
  • Current smoker or utilizing nicotine patches or gum
  • Participation in a hormonal drug study within past month.

结局指标

主要结局

Testosterone Blood Serum Concentration

时间窗: 7 days

Blood for measurement of serum testosterone was obtained prior to the 1st, 5th and 6th dose of GIPET™-enhanced oral acyline and 0.5,1, 1.5, 2, 3, 4, 6, 8, 12, 24, 36, 48 and 60 hours after the 7th dose.

次要结局

  • FSH Blood Serum Concentration(7 days)
  • LH Blood Serum Concentration(7 days)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验